AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Return
31.39%
This Quarter Return
+15.94%
1 Year Return
+31.39%
3 Year Return
+70.33%
5 Year Return
+145.91%
10 Year Return
–
AUM
$33.8B
AUM Growth
+$4.19B
(+14%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
21.76%
Holding
2,483
New
104
Increased
1,329
Reduced
987
Closed
53
Top Buys
| 1 |
Tesla
TSLA
|
$58M |
| 2 |
Unilever
UL
|
$52.4M |
| 3 |
Walt Disney
DIS
|
$18.3M |
| 4 |
Microsoft
MSFT
|
$17.5M |
| 5 |
Morgan Stanley
MS
|
$14.2M |
Top Sells
| 1 |
UN
Unilever NV New York Registry Shares
UN
|
$48.8M |
| 2 |
AT&T
T
|
$25.6M |
| 3 |
Johnson & Johnson
JNJ
|
$21.3M |
| 4 |
Amazon
AMZN
|
$16M |
| 5 |
Biogen
BIIB
|
$11.7M |
Sector Composition
| 1 | Technology | 25.51% |
| 2 | Financials | 13.6% |
| 3 | Healthcare | 13.1% |
| 4 | Consumer Discretionary | 11.54% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Viking Therapeutics
VKTX
$2.99B
| $150K | ﹤0.01% |
26,697
+14,717
| +123% | +$82.7K |
|
|
ATNX
2352
DELISTED
Athenex, Inc. Common Stock
ATNX
| $150K | ﹤0.01% |
678
+114
| +20% | +$25.2K |
|
|
ADAP
2353
Adaptimmune Therapeutics
ADAP
$13.2M
| $149K | ﹤0.01% |
27,556
-6,346
| -19% | -$34.3K |
|
|
RDHL
2354
Redhill Biopharma
RDHL
$2.98M
| $149K | ﹤0.01% |
+18
| New | +$149K |
|
|
ATRS
2355
DELISTED
Antares Pharma, Inc.
ATRS
| $149K | ﹤0.01% |
37,381
+4,105
| +12% | +$16.4K |
|
|
APTS
2356
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $148K | ﹤0.01% |
20,031
-4,472
| -18% | -$33K |
|
2357
Hackett Group
HCKT
$568M
| $147K | ﹤0.01% |
10,196
-266
| -3% | -$3.84K |
|
2358
FuelCell Energy
FCEL
$89.8M
| $142K | ﹤0.01% |
+424
| New | +$142K |
|
2359
HF Foods Group
HFFG
$168M
| $142K | ﹤0.01% |
18,929
-4,415
| -19% | -$33.1K |
|
|
VRAY
2360
DELISTED
ViewRay, Inc.
VRAY
| $142K | ﹤0.01% |
37,109
+1,137
| +3% | +$4.35K |
|
|
TCDA
2361
DELISTED
Tricida, Inc. Common Stock
TCDA
| $140K | ﹤0.01% |
19,916
-56,539
| -74% | -$397K |
|
2362
Arlo Technologies
ARLO
$1.88B
| $139K | ﹤0.01% |
17,818
+6,266
| +54% | +$48.9K |
|
2363
Liberty Latin America Class C
LILAK
$1.65B
| $135K | ﹤0.01% |
12,187
-74
| -0.6% | -$820 |
|
|
AMRN
2364
Amarin Corp
AMRN
$315M
| $131K | ﹤0.01% |
1,341
+785
| +141% | +$76.7K |
|
|
CNSL
2365
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $130K | ﹤0.01% |
26,615
-8,705
| -25% | -$42.5K |
|
|
AGEN
2366
Agenus
AGEN
$135M
| $128K | ﹤0.01% |
2,045
+1,129
| +123% | +$70.7K |
|
2367
Hanmi Financial
HAFC
$753M
| $127K | ﹤0.01% |
11,205
-4,461
| -28% | -$50.6K |
|
2368
Harmonic Inc
HLIT
$1.13B
| $126K | ﹤0.01% |
17,042
+2,915
| +21% | +$21.6K |
|
|
KDMN
2369
DELISTED
Kadmon Holdings, Inc.
KDMN
| $121K | ﹤0.01% |
29,252
+2,649
| +10% | +$11K |
|
2370
SM Energy
SM
$3.06B
| $115K | ﹤0.01% |
18,768
-15,127
| -45% | -$92.7K |
|
2371
MBIA
MBI
$394M
| $112K | ﹤0.01% |
16,994
-2,636
| -13% | -$17.4K |
|
|
LGF.B
2372
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $112K | ﹤0.01% |
10,804
-1,427
| -12% | -$14.8K |
|
|
AUTL
2373
Autolus Therapeutics
AUTL
$378M
| $111K | ﹤0.01% |
12,419
+1,047
| +9% | +$9.36K |
|
2374
CytomX Therapeutics
CTMX
$353M
| $110K | ﹤0.01% |
16,834
-3,001
| -15% | -$19.6K |
|
|
CBAY
2375
DELISTED
Cymabay Therapeutics
CBAY
| $110K | ﹤0.01% |
19,184
+6,842
| +55% | +$39.2K |
|